Blog Posts

Latin America PoC Diagnostics Market Size, Overview, Share and Forecast 2031

Posted by Prajakta on September 23, 2024 at 7:57am 0 Comments

The Latin America PoC Diagnostics Market in 2023 is US$ 3.55 billion, and is expected to reach US$ 6.34 billion by 2031 at a CAGR of 7.52%.



FutureWise Research published a report that analyzes Latin America PoC Diagnostics Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of… Continue

DCGI Finds First MRNA Vaccine Safe, Gives Nods For Phase 2/3 Trials

The Drug Controller General of India has approved the Phase 2 and 3 clinical trials of India’s first Covid-19 mRNA vaccine.

Pune-based pharma major Gennova Biopharmaceuticals Ltd is developing the nation’s first mRNA-based Covid-19 vaccine. It is among a few pharmaceutical firms worldwide, including Moderna Inc and Pfizer Inc, to use mRNA technology in its coronavirus shot. These vaccines do not use a live virus to generate an immune response but prompt the human body to make a protein that triggers one.
https://www.canindia.com/dcgi-finds-first-mrna-vaccine-safe-gives-n...

Views: 0

Comment

You need to be a member of On Feet Nation to add comments!

Join On Feet Nation

© 2024   Created by PH the vintage.   Powered by

Badges  |  Report an Issue  |  Terms of Service